Physician

Kavitha M Prezzano, MD

According to 2025 Medicare claims, Kavitha Prezzano, MD (NPI: 1265819312) practices radiation oncology in the Syracuse, NY market, with the plurality of this provider's patient population coming from Onondaga, NY. This provider's primary affiliated billing organization is HEMATOLOGY-ONCOLOGY ASSOCIATES OF CNY, PC (NPI: 1902885429; TIN: 161184100) and primary practice location at 13057-9248.

Prezzano's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 179 traditional Medicare patients, billed 8,517 HCPCS/CPT codes, and received $700,027 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 35 prescription claims across 24 beneficiaries totaling $567 in drug costs. Open Payments data shows 1 records totaling $26. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $4,557 to $567. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$350K$700K2020 Medicare payment: $279,502 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $527,559 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $627,469 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $542,510 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $700,027 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201038,741$279,502
20211586,901$527,559
20221505,349$627,469
202318710,019$542,510
20241798,517$700,027

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.0K$6.0K2015 Drug cost: $4,557 (USD; Tot_Drug_Cst)2016 Drug cost: $6,020 (USD; Tot_Drug_Cst)2017 Drug cost: $782 (USD; Tot_Drug_Cst)2018 Drug cost: $1,274 (USD; Tot_Drug_Cst)2019 Drug cost: $1,003 (USD; Tot_Drug_Cst)2020 Drug cost: $190 (USD; Tot_Drug_Cst)2021 Drug cost: $720 (USD; Tot_Drug_Cst)2022 Drug cost: $962 (USD; Tot_Drug_Cst)2023 Drug cost: $304 (USD; Tot_Drug_Cst)2024 Drug cost: $567 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151942$4,557
20163781$6,020
20172433$782
20181727$1,274
20191316$1,003
2020N/R11$190
20211928$720
20222950$962
20231316$304
20242435$567

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more74118$95
77336Continuing radiation therapy consultation per week61138$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7291$63
77300Calculation of radiation therapy dose58350$49
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's6668$13

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$26Siemens Medical Solutions USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kavitha M. Prezzano, MD?

Tedicare shows public-source Medicare data for Kavitha M. Prezzano, MD (NPI 1265819312), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kavitha M. Prezzano, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kavitha M. Prezzano, MD?

Kavitha M. Prezzano, MD is linked to HEMATOLOGY-ONCOLOGY ASSOCIATES OF CNY, PC (billing NPI 1902885429) in the available physician profile data.

Does Kavitha M. Prezzano, MD have Open Payments data?

Kavitha M. Prezzano, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.